Published in Steroids on February 09, 2015
BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis. Allergy (2016) 0.79
A gradient of glucocorticoid sensitivity among helper T cell cytokines. Cytokine Growth Factor Rev (2016) 0.76
Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques (1988) 6.83
DNA binding of the glucocorticoid receptor is not essential for survival. Cell (1998) 6.40
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell (1990) 5.59
The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins. EMBO J (1986) 3.17
Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol (1995) 3.11
Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell (2005) 2.39
Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene (1999) 2.19
Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer. J Natl Cancer Inst (2002) 1.95
Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab (2000) 1.74
Theoretical analysis of mutation hotspots and their DNA sequence context specificity. Mutat Res (2003) 1.70
Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death Differ (2004) 1.68
International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev (2006) 1.60
Inherited and de novo androgen receptor gene mutations: investigation of single-case families. J Pediatr (1998) 1.55
A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem (1997) 1.43
Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol Cell Biol (2007) 1.28
Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab (2001) 1.22
Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol (2008) 1.19
Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) (2001) 1.18
Sequence and structure signatures of cancer mutation hotspots in protein kinases. PLoS One (2009) 1.14
Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clin Endocrinol (Oxf) (2006) 1.08
Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. J Biol Chem (2000) 1.08
Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J (2009) 1.01
Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Hum Mutat (2007) 1.00
Chromosome assignment of a murine glucocorticoid receptor gene (Grl-1) using intraspecies somatic cell hybrids. Cell (1980) 0.97
Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells. Mol Endocrinol (2011) 0.94
A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance. Mol Endocrinol (1993) 0.86
Specific receptors control steroid sensitivity in lymphoma cell hybrids. Mol Cell Endocrinol (1980) 0.86
Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor. Horm Res (2000) 0.84
Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome. J Clin Endocrinol Metab (2004) 0.83
Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr Disord (2014) 0.82
Assignment of the human gene for the glucocorticoid receptor to chromosome 5. Proc Natl Acad Sci U S A (1985) 0.78